首页> 外国专利> Amide Compound with Inhibitory activity of FAAH, a method for its preparation and Neuroprotective Agents for Treatment or prophylaxis of cerebrovascular disorders.

Amide Compound with Inhibitory activity of FAAH, a method for its preparation and Neuroprotective Agents for Treatment or prophylaxis of cerebrovascular disorders.

机译:具有FAAH抑制活性的酰胺化合物,其制备方法和神经保护剂,用于治疗或预防脑血管疾病。

摘要

It provides a FAAH inhibitor and an agent for the prophylaxis or Therapy of cerebrovascular Disorders and Sleep Disorders that comprise it.Claim 1: a compound characterized by being represented by the formula (1) wherein z is o or s, R1 can be substituted aryl or Heterocyclic Group, which can be replaced; A1A is a H Atom, a Hydrocarbon group which may be substituted hydroxyl, alkoxyl, PU Can be replaced, ariloxilo amino can be replaced, which can be replaced,Cicloamino saturated or 5 to 7 members can be replaced; R2 is piperidin 1.4 - dilaurate which can be replaced, or piperazin - 1.4 - dilaurate which can be replaced; R3 is a group formed by removing two H Atoms and an Aromatic Heterocyclic Group of 5 members who has 1 3 heteroatoms s Selected n, o and S can also be replaced, co -- CO or co NH -; and R4 is a Hydrocarbon group which may be replaced, or a Heterocyclic Group can be replaced, with the condition that when R3 is co, co or co - or - NH -, R1 is benzoisoxazolilo (with the condition; n - (4-fluorophenyl) - 4 - [5 - (4-fluorophenyl) - 4 - pyridin-4-yl - 1H pyrazole - 3 - il 1) piperidin - carboxamide,N - phenyl 4 - (4 - [3 - (trifluoromethyl) phenyl] - 1H imidazole piperidin yl) - 2 - 1 - carboxamide and 4 - [4 - (4-methylphenyl) - 5 - (2 - [2 - (trifluoromethyl) pyrimidin-4-yl) methyl) pyrimidine - 5 - il) - 1H imidazol-1-yl] - N - [3 - (trifluoromethyl) phenyl] - carboxamide piperidin 1 are excluded), or a Salt thereof.Claim 21 that is characterized by: a procedure to produce a compound of formula (2) where R1 is that can be substituted aryl or Heterocyclic Group, which can be replaced; R4 is a Hydrocarbon group which may be replaced, or a Heterocyclic Group that can be Replaced; X is o or s; e and N or C, or a Salt thereof,That includes subjecting a ureidacion reaction of a compound of formula (3), wherein each symbol is as defined above, or a Salt thereof.
机译:它提供了一种FAAH抑制剂,以及一种包含FAAH抑制剂的脑血管疾病和睡眠障碍的预防或治疗药物。权利要求1:一种化合物,其特征在于由式(1)表示,其中z为o或s,R1可以为取代的芳基或可取代的杂环基; A1A是H原子,可以被取代的烃基羟基,烷氧基,PU可以被取代,阿利西洛氨基可以被取代,其可以被取代,环氨基饱和或5至7个成员可以被取代; R 2是哌啶1.4-二月桂酸酯可以被替换,或者哌嗪1.4-二月桂酸酯可以被替换; R3是通过除去两个H原子而形成的基团,该芳族杂环基团由5个成员组成,它们具有1 3个杂原子,被选择的n,o和S也可以被取代,co-CO或co NH-;并且R4是可以被取代的烃基或可以被取代的杂环基,条件是当R3是co,co或co-或-NH-时,R1是苯并异恶唑基(条件是; n-(4-氟苯基)-4-[5--(4-氟苯基)-4-吡啶-4-基-1H吡唑-3-il 1)哌啶-羧酰胺,N-苯基4-(4-[3-(三氟甲基)苯基] -1H咪唑哌啶基)-2-1-羧酰胺和4-[4-(4-甲基苯基)-5-(2-[2-(三氟甲基)嘧啶-4-基)甲基)嘧啶-5-il)-权利要求21,其特征在于:制备式(2)的化合物的步骤,其中,1H咪唑-1-基] -N- [3-(三氟甲基)苯基]-羧酰胺哌啶1或其盐不包括在内。 R1是可以被取代的芳基或杂环基,可以被取代; R4是可以被取代的烃基或可以被取代的杂环基; X是o或s; e和N或C或其盐,其包括使其中每个符号如上所定义的式(3)化合物或其盐进行尿苷酸反应。

著录项

  • 公开/公告号AR052141A1

    专利类型

  • 公开/公告日2007-03-07

    原文格式PDF

  • 申请/专利权人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;

    申请/专利号AR2005P104834

  • 申请日2005-11-17

  • 分类号C07D277/42;C07D285/08;C07D413/12;C07D413/14;C07D417/12;C07D417/14;A61K31/496;A61K31/497;A61K31/5377;A61P9/10;A61P25/00;C07D261/14;C07D213/75;C07D213/53;C07D307/52;C07D333/72;C07D333/22;C07D235/10;C07D277/48;C07D261/18;C07D211/58;C07D333/36;C07D239/42;C07D271/10;C07D211/26;

  • 国家 AR

  • 入库时间 2022-08-21 20:59:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号